Ganirelix Labatec 0,25 mg, solution injectable en seringue préremplie
7680685490018
CH-68549
Lösung
Associated product:
GANIRELIX Labatec sol inj 0.25 mg/0.5ml ser pré
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.023 MG | Substance | HBESI |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 68549
- Drug name
- Ganirelix Labatec, solution injectable en seringue préremplie
- Galenic form
- LSILF
- ATC Code
- H01CC01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 04/08/2022
- Authorization expiration date
- 03/08/2027
- IT Number
- 07.09.0.
- Domain
- Human medicine
Package details
- Description (FR)
- GANIRELIX Labatec sol inj 0.25 mg/0.5ml ser pré
- Description (DE)
- GANIRELIX Labatec Inj Lös 0.25 mg/0.5ml Fertspr
- Market launch
- 04/08/2022
- Narcotic (BTM)
- No
Other package sizes (1)
GANIRELIX Labatec sol inj 0.25 mg/0.5ml 5 pce
5 FESP
GTIN: 7680685490025